Global Short Bowel Syndrome (SBS) Drugs Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 95

Report ID: 19409

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.
In 2018, the global Short Bowel Syndrome (SBS) Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Short Bowel Syndrome (SBS) Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Short Bowel Syndrome (SBS) Drugs development in United States, Europe and China.

The key players covered in this study
Merck
Shire
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Market segment by Type, the product can be split into
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other

Market segment by Application, split into
Hospitals
Clinics
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Short Bowel Syndrome (SBS) Drugs status, future forecast, growth opportunity, key market and key players.
To present the Short Bowel Syndrome (SBS) Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Short Bowel Syndrome (SBS) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Glucagon-Like Peptide-2 (GLP-2)
1.4.3 Growth Hormone
1.4.4 Glutamine
1.4.5 Other
1.5 Market by Application
1.5.1 Global Short Bowel Syndrome (SBS) Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Short Bowel Syndrome (SBS) Drugs Market Size
2.2 Short Bowel Syndrome (SBS) Drugs Growth Trends by Regions
2.2.1 Short Bowel Syndrome (SBS) Drugs Market Size by Regions (2014-2025)
2.2.2 Short Bowel Syndrome (SBS) Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Short Bowel Syndrome (SBS) Drugs Market Size by Manufacturers
3.1.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Short Bowel Syndrome (SBS) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Short Bowel Syndrome (SBS) Drugs Key Players Head office and Area Served
3.3 Key Players Short Bowel Syndrome (SBS) Drugs Product/Solution/Service
3.4 Date of Enter into Short Bowel Syndrome (SBS) Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-2019)
4.2 Global Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
5.2 Short Bowel Syndrome (SBS) Drugs Key Players in United States
5.3 United States Short Bowel Syndrome (SBS) Drugs Market Size by Type
5.4 United States Short Bowel Syndrome (SBS) Drugs Market Size by Application

6 Europe
6.1 Europe Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
6.2 Short Bowel Syndrome (SBS) Drugs Key Players in Europe
6.3 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Type
6.4 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Application

7 China
7.1 China Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
7.2 Short Bowel Syndrome (SBS) Drugs Key Players in China
7.3 China Short Bowel Syndrome (SBS) Drugs Market Size by Type
7.4 China Short Bowel Syndrome (SBS) Drugs Market Size by Application

8 Japan
8.1 Japan Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
8.2 Short Bowel Syndrome (SBS) Drugs Key Players in Japan
8.3 Japan Short Bowel Syndrome (SBS) Drugs Market Size by Type
8.4 Japan Short Bowel Syndrome (SBS) Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
9.2 Short Bowel Syndrome (SBS) Drugs Key Players in Southeast Asia
9.3 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size by Type
9.4 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size by Application

10 India
10.1 India Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
10.2 Short Bowel Syndrome (SBS) Drugs Key Players in India
10.3 India Short Bowel Syndrome (SBS) Drugs Market Size by Type
10.4 India Short Bowel Syndrome (SBS) Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
11.2 Short Bowel Syndrome (SBS) Drugs Key Players in Central & South America
11.3 Central & South America Short Bowel Syndrome (SBS) Drugs Market Size by Type
11.4 Central & South America Short Bowel Syndrome (SBS) Drugs Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.1.4 Merck Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Shire
12.2.1 Shire Company Details
12.2.2 Company Description and Business Overview
12.2.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.2.4 Shire Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.2.5 Shire Recent Development
12.3 Emmaus Medical
12.3.1 Emmaus Medical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.3.4 Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.3.5 Emmaus Medical Recent Development
12.4 Ardelyx
12.4.1 Ardelyx Company Details
12.4.2 Company Description and Business Overview
12.4.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.4.4 Ardelyx Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.4.5 Ardelyx Recent Development
12.5 Naia Pharmaceuticals
12.5.1 Naia Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.5.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.5.5 Naia Pharmaceuticals Recent Development
12.6 Nutrinia
12.6.1 Nutrinia Company Details
12.6.2 Company Description and Business Overview
12.6.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.6.4 Nutrinia Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.6.5 Nutrinia Recent Development
12.7 OxThera
12.7.1 OxThera Company Details
12.7.2 Company Description and Business Overview
12.7.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.7.4 OxThera Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.7.5 OxThera Recent Development
12.8 Sancilio Pharmaceuticals
12.8.1 Sancilio Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.8.4 Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.8.5 Sancilio Pharmaceuticals Recent Development
12.9 Zealand Pharma
12.9.1 Zealand Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.9.4 Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.9.5 Zealand Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details